Teva Pharmaceutical Industries Ltd (TEVA):企業の財務・戦略的SWOT分析

◆英語タイトル:Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1652
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:85
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Teva Pharmaceutical Industries Ltd (TEVA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Teva Pharmaceutical Industries Ltd (Teva) discovers, develops, manufactures and commercializes generic and specialty medicines. It provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, cancer, women’s health and other therapy areas. The company offers generic medicines in a range of dosage forms including capsules, tablets, injectables, liquids, inhalants, creams and ointments. Teva also provides over-the-counter (OTC) products, besides active pharmaceutical ingredients (APIs). The company conducts its worldwide operations through a network of global subsidiaries. Teva is headquartered in Petach Tikva, Israel.

Teva Pharmaceutical Industries Ltd Key Recent Developments

Apr 21,2020 Teva drives positive impact in response to COVID-19 pandemic
Mar 16,2020 Teva Update Regarding COVID-19
Feb 21,2020 Teva is doing to help save the lives of thousands of children with cancer and blood disorders in Africa
Feb 12,2020 Teva reports fourth quarter and full year 2019 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Teva Pharmaceutical Industries Ltd – Key Facts
Teva Pharmaceutical Industries Ltd – Key Employees
Teva Pharmaceutical Industries Ltd – Key Employee Biographies
Teva Pharmaceutical Industries Ltd – Major Products and Services
Teva Pharmaceutical Industries Ltd – History
Teva Pharmaceutical Industries Ltd – Company Statement
Teva Pharmaceutical Industries Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Teva Pharmaceutical Industries Ltd – Business Description
Geographical Segment: Europe
Target Markets
Performance
Overview
Geographical Segment: International Markets
Target Markets
Performance
Geographical Segment: North America
Target Markets
Performance
Overview
R&D Overview
Teva Pharmaceutical Industries Ltd – Corporate Strategy
Teva Pharmaceutical Industries Ltd – SWOT Analysis
SWOT Analysis – Overview
Teva Pharmaceutical Industries Ltd – Strengths
Teva Pharmaceutical Industries Ltd – Weaknesses
Teva Pharmaceutical Industries Ltd – Opportunities
Teva Pharmaceutical Industries Ltd – Threats
Teva Pharmaceutical Industries Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Teva Pharmaceutical Industries Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 21, 2020: Teva drives positive impact in response to COVID-19 pandemic
Mar 16, 2020: Teva Update Regarding COVID-19
Feb 21, 2020: Teva is doing to help save the lives of thousands of children with cancer and blood disorders in Africa
Feb 12, 2020: Teva reports fourth quarter and full year 2019 financial results
Feb 12, 2020: Shepherd, Finkelman, Miller & Shah secures 29% Whistleblower Award in Teva Pharmaceuticals false claims Act case that recently settled for $54 million
Jan 06, 2020: Teva Pharmaceuticals agrees to pay $54 million to settle Shepherd, Finkelman, Miller & Shah False Claims Act Qui Tam Case
Nov 26, 2019: Teva forms drug research partnerships with Israeli institutes
Nov 07, 2019: Teva announces appointment of new Chief Financial Officer
Nov 07, 2019: Teva reports third quarter 2019 financial results
Nov 06, 2019: Mount Sinai researchers develop novel method to identify patterns among patients with multiple chronic conditions
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Teva Pharmaceutical Industries Ltd, Key Facts
Teva Pharmaceutical Industries Ltd, Key Employees
Teva Pharmaceutical Industries Ltd, Key Employee Biographies
Teva Pharmaceutical Industries Ltd, Major Products and Services
Teva Pharmaceutical Industries Ltd, History
Teva Pharmaceutical Industries Ltd, Subsidiaries
Teva Pharmaceutical Industries Ltd, Joint Venture
Teva Pharmaceutical Industries Ltd, Key Competitors
Teva Pharmaceutical Industries Ltd, Ratios based on current share price
Teva Pharmaceutical Industries Ltd, Annual Ratios
Teva Pharmaceutical Industries Ltd, Annual Ratios (Cont...1)
Teva Pharmaceutical Industries Ltd, Annual Ratios (Cont...2)
Teva Pharmaceutical Industries Ltd, Interim Ratios
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Teva Pharmaceutical Industries Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Teva Pharmaceutical Industries Ltd, Performance Chart (2015 - 2019)
Teva Pharmaceutical Industries Ltd, Ratio Charts
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Teva Pharmaceutical Industries Ltd (TEVA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AyoxxA Biosystems GmbH:医療機器:M&Aディール及び事業提携情報
    Summary AyoxxA Biosystems GmbH (AyoxxA) is a life science tools company that provides protein analysis solutions. The company offers multiple detection kits, cytokine detection kits, human inflammation kits, mouse inflammation kits, and human opthalmology kits. Its services include complete testing …
  • Laboratoires Thea SA:企業の戦略的SWOT分析
    Laboratoires Thea SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Schibsted ASA:企業のM&A・事業提携・投資動向
    Schibsted ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Schibsted ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Breeze-Eastern Corporation:企業の戦略・SWOT・財務情報
    Breeze-Eastern Corporation - Strategy, SWOT and Corporate Finance Report Summary Breeze-Eastern Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Precision Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Precision Biologics Inc (PBI), a subsidiary of NantWorks LLC, is a clinical stage biotechnology company. The company offers cancer vaccines, antigens and antibodies, pipelines, diagnostics, therapeutics, clinical trials, tumor specific antigens, companion diagnostic programs, and diagnostic …
  • Sitara Chemical Industries Ltd (SITC):企業の財務・戦略的SWOT分析
    Sitara Chemical Industries Ltd (SITC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • The Lubrizol Corp:企業の戦略的SWOT分析
    The Lubrizol Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • PT Bank Central Asia Tbk:企業の戦略・SWOT・財務情報
    PT Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Burger-In Oy:戦略・SWOT・企業財務分析
    Burger-In Oy - Strategy, SWOT and Corporate Finance Report Summary Burger-In Oy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Chongqing Rural Commercial Bank Co., Ltd.:戦略・SWOT・企業財務分析
    Chongqing Rural Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chongqing Rural Commercial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Peco Energy Company:電力:M&Aディール及び事業提携情報
    Summary PECO Energy Company (PECO), a subsidiary of Exelon Corporation, is a public utility that purchases and sells electricity and gas, and provides electricity transmission and distribution, and gas distribution services. It supplies electricity and gas to residential, commercial, and industrial …
  • LG Electronics Inc (066570):電力:M&Aディール及び事業提携情報
    Summary LG Electronics, Inc. (LG Electronics), a subsidiary of LG Corp, manufactures and markets consumer electronics and home appliances. Its product portfolio includes television, monitors, personal computers, audio and video equipment, refrigerators, washing machines, dishwashers, cooking applian …
  • Rodin Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rodin Therapeutics Inc (Rodin Therapeutics) discovers and develops novel medicines targeting epigenetics and novel chemical strategies for cognitive impairment of neurological and neuropsychiatric disorders. Its translational therapeutic strategy harnesses the power of epigenetic regulation …
  • Amazon Web Services Inc:企業の戦略・SWOT・財務分析
    Amazon Web Services Inc - Strategy, SWOT and Corporate Finance Report Summary Amazon Web Services Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Glow Energy Public Co Ltd (GLOW)-エネルギー分野:企業M&A・提携分析
    Summary Glow Energy Public Company Limited (Glow Energy), a subsidiary of Engie S.A., is an energy utility company. It generates and supplies electricity to Electricity Generating Authority of Thailand (EGAT). The company also generates and supplies electricity, steam, processed water and chilled wa …
  • LED Medical Diagnostics Inc (LMD):医療機器:M&Aディール及び事業提携情報
    Summary LED Medical Diagnostics Inc (LED Medical), a subsidiary of Searchlight Capital Corp, is a dental imaging technology. The company delivers imaging software and systems. Its products include Velscope Vx system, a device for the enhanced visualization of oral mucosal abnormalities; VELscope Vx …
  • JFE Holdings, Inc.:戦略・SWOT・企業財務分析
    JFE Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary JFE Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • AptarGroup Inc:企業の戦略・SWOT・財務分析
    AptarGroup Inc - Strategy, SWOT and Corporate Finance Report Summary AptarGroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sygnis AG (LIO1)-医療機器分野:企業M&A・提携分析
    Summary Sygnis AG (Sygnis), formerly Sygnis Pharma AG is a biopharmaceutical company that develops novel products and tools in fields of molecular biology. The company undertakes development and marketing of new molecular biological technologies for DNA amplification and sequencing. Its products inc …
  • PT Charoen Pokphand Indonesia Tbk (CPIN):企業の財務・戦略的SWOT分析
    PT Charoen Pokphand Indonesia Tbk (CPIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆